glycopyrrolate has been researched along with Drooling in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.08) | 18.7374 |
1990's | 6 (12.50) | 18.2507 |
2000's | 9 (18.75) | 29.6817 |
2010's | 23 (47.92) | 24.3611 |
2020's | 9 (18.75) | 2.80 |
Authors | Studies |
---|---|
Barbi, E; Galimberti, AMC; Maestro, A; Maximova, N; Torelli, L; Tumminelli, C; Zanon, D | 1 |
Aversa, M; Bella, GD; Campana, A; Castelli, E; De Ioris, MA; De Peppo, F; Geremia, C; Lettori, D; Lovardi, E; Scarselli, A; Scrocca, R; Staccioli, S | 1 |
Castelli, E; Della Bella, G; Vigevano, F | 1 |
Faria-E-Silva, AL; Leal, PC; Reis, A; Santos Junior, LC; Santos, JR | 1 |
Auvin, S; Dinomais, M; Fayoux, P; Pouchain, D; Probert, N; Shaw, H; Texier, N; Villain, F | 1 |
Guzys, AT; Reddihough, DS; Reid, SM; Westbury, C | 1 |
Al-Shorafat, DM; Basndwah, A; de Oliveira, LM; Fox, SH; Freitas, E; Grimes, D; Lopez, MR; Lui, JP; Mestre, TA; Zhang, T | 1 |
Plunkett, C | 1 |
Rohrbach-Volland, S; Steffen, A | 1 |
Cadwgan, J; Cole, M; Colver, AF; O'Hare, AE; Parr, JR; Pennington, L; Stocken, D; Todhunter, E; Tuffrey, C; Williams, J | 1 |
Sivaramakrishnan, G; Sridharan, K | 1 |
Hilbert, T; Kirchertz, R | 1 |
Bäumer, T; Beutner, D; Degenkolb-Weyers, S; Groß, M; Grosheva, M; Guntinas-Lichius, O; Hakim, S; Jost, W; Kahl, KG; Laskawi, R; Lencer, R; Löhler, J; Meyners, T; Rohrbach-Volland, S; Schönweiler, R; Schröder, S; Schröder, SC; Schröter-Morasch, H; Schuster, M; Steffen, A; Steinlechner, S; Urban, R | 1 |
Beutner, D; Guntinas-Lichius, O; Hakim, S; Jost, W; Kahl, KG; Laskawi, R; Lencer, R; Mall, V; Mehrhoff, FW; Meyners, T; Schönweiler, R; Schröder, S; Schröter-Morasch, H; Schuster, M; Steffen, A; Steinlechner, S; Winterhoff, J; Zenk, J | 1 |
Colver, A; Fairhurst, C; Lodh, R; O'Hare, A; Parr, JR; Pennington, L; Steen, N; Weldon, E; Williams, J | 1 |
Munoli, RN; Praharaj, SK; Sharma, PS | 1 |
Blissit, KT; Latham, C; Pacheco-Perez, J; Tillery, E | 1 |
Chaudhry, I; Chu, S; Deakin, JF; Drake, RJ; Husain, N; Qurashi, I | 1 |
Hong, SK; Kim, JM; Lee, DH; Lee, ZI; Park, D; Woo, SB; Yu, KJ | 1 |
Cahn, W; Colen-de Koning, JC; Doodeman, HJ; Egberts, TC; Heerdink, ER; Man, WH; Schulte, PF; van Haelst, IM; Wilting, I | 1 |
Chiang, KT; Ho, PS; Lee, WK; Liang, CS; Shen, LJ; Yang, FW | 1 |
Arbouw, ME; Egberts, TC; Guchelaar, HJ; Koopmann, M; Movig, KL; Neef, C; Poels, PJ; van Vugt, JP | 1 |
Cosaert, K; Spriet, I; Willems, L | 1 |
Banerjee, K; Buswell, CA; Fairhurst, C; O'Hare, A; Parr, JR; Pennington, L; Williams, J | 1 |
Ahmedzai, SH; Cooper-Knock, J; Shaw, P | 1 |
Pennington, L; Smith, M; Walshe, M | 2 |
Eiland, LS | 1 |
Rowson, J; Squires, N; Wills, A | 1 |
Garnock-Jones, KP | 1 |
Tscheng, DZ | 1 |
Blasco, PA | 1 |
DEVANEY, GT; JUNIPER, K; SMITH, TJ; STEWART, JR | 1 |
Friedman, A; Potulska, A | 1 |
Duggal, HS | 1 |
Cooper, EB; Lee, RH; Nusrat, N; Robb, AS; Siedel, JV | 1 |
Lieblich, SE | 1 |
Blasco, PA; Stansbury, JC | 1 |
Stern, LM | 1 |
Bachrach, SJ; Trzcinski, K; Walter, RS | 1 |
Amass, C; Lucas, V | 1 |
Olsen, AK; Sjøgren, P | 1 |
Eriksen, T; Grinna, T; Kvalshaugen, H; Lind, AB; Neverlien, PO; Sorumshagen, L | 1 |
Bachrach, SJ; Barker, T; Childs, J; Lakin, RC; Mier, RJ; Moran, M | 1 |
Eriksen, T; Grinna, T; Kvalshaugen, H; Lind, AB; Neverlien, PO; Sørumshagen, L | 1 |
Chye, R; Fardell, B; Strutt, R | 1 |
11 review(s) available for glycopyrrolate and Drooling
Article | Year |
---|---|
Effectiveness of the pharmacological treatments for sialorrhea in patients with Parkinson's disease: a systematic review and network meta-analysis.
Topics: Botulinum Toxins, Type A; Glycopyrrolate; Humans; Network Meta-Analysis; Parkinson Disease; Sialorrhea | 2023 |
Pharmacological interventions for treating sialorrhea associated with neurological disorders: A mixed treatment network meta-analysis of randomized controlled trials.
Topics: Benztropine; Botulinum Toxins, Type A; Child; Child, Preschool; Female; Glycopyrrolate; Humans; Muscarinic Antagonists; Nervous System Diseases; Network Meta-Analysis; Randomized Controlled Trials as Topic; Scopolamine; Sialorrhea | 2018 |
[Glycopyrrolate, an alternative to deptropine citratie when treating sialorrhea].
Topics: Glycopyrrolate; Histamine H1 Antagonists; Humans; Ipratropium; Muscarinic Antagonists; Scopolamine; Sialorrhea; Tropanes | 2010 |
Interventions for drooling in children with cerebral palsy.
Topics: Adolescent; Adult; Benztropine; Botulinum Toxins, Type A; Cerebral Palsy; Child; Child, Preschool; Female; Glycopyrrolate; Humans; Infant; Male; Neuromuscular Agents; Randomized Controlled Trials as Topic; Salivation; Sialorrhea; Young Adult | 2012 |
Glycopyrrolate for chronic drooling in children.
Topics: Biological Availability; Child; Chronic Disease; Clinical Trials as Topic; Glycopyrrolate; Humans; Muscarinic Antagonists; Sialorrhea | 2012 |
The management of drooling in adults with neurological conditions.
Topics: Administration, Cutaneous; Adult; Amitriptyline; Atropine; Behavior Therapy; Botulinum Toxins, Type A; Cerebral Palsy; Child; Cholinergic Antagonists; Cooperative Behavior; Deglutition Disorders; Glycopyrrolate; Humans; Interdisciplinary Communication; Motor Neuron Disease; Nervous System Diseases; Parkinson Disease; Patient Care Team; Salivary Glands; Scopolamine; Sialorrhea | 2012 |
Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.
Topics: Administration, Oral; Adolescent; Cerebral Palsy; Child; Chronic Disease; Clinical Trials as Topic; Glycopyrrolate; Humans; Muscarinic Antagonists; Sialorrhea; Solutions | 2012 |
Interventions for drooling in children with cerebral palsy.
Topics: Adolescent; Adult; Benztropine; Botulinum Toxins, Type A; Cerebral Palsy; Child; Child, Preschool; Controlled Clinical Trials as Topic; Female; Glycopyrrolate; Humans; Infant; Male; Neuromuscular Agents; Randomized Controlled Trials as Topic; Sialorrhea; Young Adult | 2012 |
Sialorrhea - therapeutic drug options.
Topics: Adolescent; Adult; Benztropine; Botulinum Toxins, Type A; Cerebral Palsy; Child; Child, Preschool; Glycopyrrolate; Humans; Randomized Controlled Trials as Topic; Scopolamine; Sialorrhea | 2002 |
Management of drooling: 10 years after the Consortium on Drooling, 1990.
Topics: Cerebral Palsy; Child; Glycopyrrolate; Humans; Muscarinic Antagonists; Outcome Assessment, Health Care; Salivary Ducts; Sialorrhea | 2002 |
Controlling sialorrhoea: a review of available treatment options.
Topics: Botulinum Toxins, Type A; Cholinergic Antagonists; Chronic Disease; Clinical Trials as Topic; Dopamine Agents; Glycopyrrolate; Humans; Levodopa; Practice Guidelines as Topic; Salivation; Sialorrhea | 2005 |
12 trial(s) available for glycopyrrolate and Drooling
Article | Year |
---|---|
Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial.
Topics: Adolescent; Child; Clinical Trials, Phase IV as Topic; Glycopyrrolate; Humans; Quality of Life; Randomized Controlled Trials as Topic; Saliva; Sialorrhea; Treatment Outcome | 2023 |
Glycopyrrolate Improves Disability From Sialorrhea in Parkinson's Disease: A 12-Week Controlled Trial.
Topics: Aged; Double-Blind Method; Glycopyrrolate; Humans; Middle Aged; Parkinson Disease; Quality of Life; Saliva; Sialorrhea; Treatment Outcome | 2020 |
Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cholinergic Antagonists; Drug Administration Schedule; Female; Follow-Up Studies; Glycopyrrolate; Humans; Male; Nervous System Diseases; Prospective Studies; Scopolamine; Sialorrhea; Single-Blind Method; Transdermal Patch; Treatment Outcome | 2018 |
The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
Topics: Adolescent; Child; Child, Preschool; Clinical Protocols; Developmental Disabilities; England; Glycopyrrolate; Humans; Muscarinic Antagonists; Nervous System Diseases; Patient Satisfaction; Research Design; Salivation; Scopolamine; Sialorrhea; Single-Blind Method; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2014 |
Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Clinical Protocols; Clozapine; Double-Blind Method; Feasibility Studies; Female; Glycopyrrolate; Humans; Male; Middle Aged; Muscarinic Antagonists; Research Design; Salivation; Schizophrenia; Scopolamine; Sialorrhea; Time Factors; Treatment Outcome; United Kingdom; Young Adult | 2016 |
The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial.
Topics: Adult; Antipsychotic Agents; Clozapine; Cross-Over Studies; Double-Blind Method; Female; Glycopyrrolate; Humans; Male; Mental Disorders; Middle Aged; Muscarinic Antagonists; Outcome Assessment, Health Care; Sialorrhea | 2017 |
Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
Topics: Adult; Antipsychotic Agents; Biperiden; Clozapine; Cognition; Cross-Over Studies; Double-Blind Method; Female; Glycopyrrolate; Humans; Male; Mental Status Schedule; Middle Aged; Muscarinic Antagonists; Schizophrenia; Sialorrhea; Taiwan | 2010 |
Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial.
Topics: Aged; Double-Blind Method; Drug Administration Schedule; Female; Glycopyrrolate; Humans; Intention to Treat Analysis; Male; Middle Aged; Muscarinic Antagonists; Parkinson Disease; Sialorrhea; Surveys and Questionnaires; Treatment Outcome | 2010 |
Glycopyrrolate treatment of chronic drooling.
Topics: Administration, Oral; Adolescent; Adult; Cerebral Palsy; Child; Child, Preschool; Chronic Disease; Constipation; Dose-Response Relationship, Drug; Glycopyrrolate; Humans; Irritable Mood; Muscarinic Antagonists; Prospective Studies; Sialorrhea | 1996 |
Preliminary study of glycopyrrolate in the management of drooling.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholinergic Antagonists; Disabled Persons; Female; Glycopyrrolate; Humans; Male; Sialorrhea; Treatment Outcome | 1997 |
Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy.
Topics: Cerebral Palsy; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Glycopyrrolate; Humans; Male; Sialorrhea | 1998 |
Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
Topics: Adolescent; Adult; Child; Child, Preschool; Cross-Over Studies; Developmental Disabilities; Dose-Response Relationship, Drug; Double-Blind Method; Glycopyrrolate; Humans; Muscarinic Antagonists; Sialorrhea | 2000 |
25 other study(ies) available for glycopyrrolate and Drooling
Article | Year |
---|---|
Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Female; Glycopyrrolate; Humans; Male; Muscarinic Antagonists; Quality of Life; Retrospective Studies; Sialorrhea; Young Adult | 2021 |
Glycopyrrolate for drooling in children with medical complexity under three years of age.
Topics: Child, Preschool; Disabled Children; Female; Glycopyrrolate; Humans; Infant; Male; Muscarinic Antagonists; Sialorrhea | 2022 |
Long-term efficacy of glycopyrrolate on sialorrhea in Goldenhar syndrome: a case report.
Topics: Child; Female; Glycopyrrolate; Goldenhar Syndrome; Humans; Quality of Life; Respiratory Tract Infections; Sialorrhea | 2022 |
Anticholinergic medications for reducing drooling in children with developmental disability.
Topics: Adolescent; Child; Child, Preschool; Cholinergic Antagonists; Developmental Disabilities; Female; Glycopyrrolate; Humans; Infant; Male; Scopolamine; Sialorrhea; Treatment Outcome; Trihexyphenidyl | 2020 |
Sialorrhoea treated with inhaled glycopyrronium.
Topics: Adult; Aged; Glycopyrrolate; Humans; Male; Muscarinic Antagonists; Pulmonary Disease, Chronic Obstructive; Sialorrhea | 2021 |
[Functional Hypersalivation in children and adults - therapy under consideration of recent guideline].
Topics: Adolescent; Adult; Child; Glycopyrrolate; Humans; Quality of Life; Salivary Ducts; Sialorrhea; Ultrasonography | 2021 |
Glycopyrronium for severe drooling in children.
Topics: Glycopyrrolate; Humans; Muscarinic Antagonists; Randomized Controlled Trials as Topic; Sialorrhea | 2017 |
A week of slow hearts: anaesthesia for eye surgery and shortage of glycopyrrolate.
Topics: Aged; Atropine; Bradycardia; Cholinergic Antagonists; Drug Combinations; Female; Germany; Glycopyrrolate; Humans; Hypotension; Intraoperative Complications; Male; Middle Aged; Ophthalmologic Surgical Procedures; Preanesthetic Medication; Reflex; Retrospective Studies; Sialorrhea; Theophylline; Vagus Nerve | 2019 |
[Hypersalivation - Update of the S2k guideline (AWMF) in short form].
Topics: Botulinum Toxins, Type A; Deglutition Disorders; Glycopyrrolate; Humans; Neurodegenerative Diseases; Salivary Glands; Sialorrhea | 2019 |
[Hypersalivation - inauguration of the S2k Guideline (AWMF) in short form].
Topics: Adult; Behavior Therapy; Botulinum Toxins, Type A; Child; Combined Modality Therapy; Cooperative Behavior; Deglutition Disorders; Evidence-Based Medicine; Exercise Therapy; Germany; Glycopyrrolate; Humans; Interdisciplinary Communication; Orthodontics; Pneumonia, Aspiration; Scopolamine; Sialorrhea | 2013 |
Low-dose glycopyrrolate for clozapine-associated sialorrhea.
Topics: Adult; Antipsychotic Agents; Clozapine; Glycopyrrolate; Humans; Male; Muscarinic Antagonists; Schizophrenia, Paranoid; Sialorrhea; Treatment Outcome | 2014 |
Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults.
Topics: Adult; Antipsychotic Agents; Clozapine; Glycopyrrolate; Humans; Male; Middle Aged; Muscarinic Antagonists; Psychotic Disorders; Schizophrenia; Sialorrhea; Young Adult | 2014 |
The Effect of Nebulized Glycopyrrolate on Posterior Drooling in Patients with Brain Injury: Two Cases of Different Brain Lesions.
Topics: Administration, Inhalation; Aged, 80 and over; Cerebral Palsy; Female; Glycopyrrolate; Hemiplegia; Humans; Infant; Male; Muscarinic Antagonists; Nebulizers and Vaporizers; Salivary Glands; Sialorrhea; Stroke; Treatment Outcome | 2017 |
In brief: Glycopyrrolate oral solution for sialorrhea.
Topics: Adolescent; Child; Child, Preschool; Drug Approval; Glycopyrrolate; Humans; Muscarinic Antagonists; Pharmaceutical Solutions; Sialorrhea; United States; United States Food and Drug Administration | 2011 |
Management of drooling in children: a survey of UK paediatricians' clinical practice.
Topics: Adolescent; Child; Child, Preschool; Disease Management; Female; Follow-Up Studies; Glycopyrrolate; Humans; Infant; Infant, Newborn; Male; Nervous System Diseases; Pediatrics; Scopolamine; Sialorrhea; Surveys and Questionnaires | 2012 |
The use of subcutaneous glycopyrrolate in the management of sialorrhoea and facilitating the use of non-invasive ventilation in amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Female; Glycopyrrolate; Humans; Injections, Subcutaneous; Middle Aged; Sialorrhea; Treatment Outcome; Ventilation | 2011 |
FINGER-TIP SWEAT-GLAND ACTIVITY AND SALIVARY SECRETION AS INDICES OF ANTICHOLINERGIC DRUG EFFECT.
Topics: Cholinergic Antagonists; Fingers; Gastric Acidity Determination; Glycopyrrolate; Humans; Methantheline; Parasympatholytics; Physiology; Quaternary Ammonium Compounds; Salivation; Sialorrhea; Sweat; Sweat Glands | 1964 |
Glycopyrrolate for clozapine-induced sialorrhea.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Clozapine; Fluphenazine; Glycopyrrolate; Humans; Male; Muscarinic Antagonists; Psychotic Disorders; Sialorrhea; Valproic Acid | 2007 |
Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents.
Topics: Adolescent; Antipsychotic Agents; Clozapine; Female; Glycopyrrolate; Humans; Male; Sialorrhea | 2008 |
Sialorrhea.
Topics: Cholinergic Antagonists; Glycopyrrolate; Hernia, Diaphragmatic; Humans; Middle Aged; Sialorrhea | 1996 |
Use of enteral glycopyrrolate in the management of drooling.
Topics: Aged; Aged, 80 and over; Female; Gastrostomy; Glycopyrrolate; Humans; Infusions, Parenteral; Sialorrhea | 1998 |
Oral glycopyrrolate alleviates drooling in a patient with tongue cancer.
Topics: Female; Glycopyrrolate; Humans; Middle Aged; Muscarinic Antagonists; Sialorrhea; Tongue Neoplasms | 1999 |
Glycopyrrolate treatment of drooling in an adult male patient with cerebral palsy.
Topics: Cerebral Palsy; Glycopyrrolate; Humans; Male; Middle Aged; Muscarinic Antagonists; Sialorrhea; Tablets; Treatment Outcome | 2000 |
[Glycopyrrolate treatment for drooling in an adult with cerebral palsy].
Topics: Administration, Oral; Adult; Cerebral Palsy; Glycopyrrolate; Humans; Muscarinic Antagonists; Sialorrhea | 2001 |
Nebulized glycopyrrolate for drooling in a motor neuron patient.
Topics: Administration, Inhalation; Female; Glycopyrrolate; Humans; Middle Aged; Motor Neuron Disease; Muscarinic Antagonists; Nebulizers and Vaporizers; Sialorrhea | 2002 |